Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer

被引：0
|
作者：
Yu-Wen He
Mei-Ling Zhao
Xin-Yun Yang
Jun Zeng
Qiu-Hua Deng
Jian-Xing He
机构：
[1] The First Affiliated Hospital of Guangzhou Medical University,Department of Pharmacy
[2] The First Affiliated Hospital of Guangzhou Medical University,Department of Thoracic Surgery
[3] State Key Laboratory of Respiratory Disease,Department of Medical Genetics and Cell Biology
[4] Guangzhou Medical University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Non-small cell lung cancer; Excision repair cross-complementation group 1; Ribonucleotide reductase M1; Thymidylate synthase; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 867
页数：6
相关论文
共 50 条
  • [1] Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer
    He, Yu-Wen
    Zhao, Mei-Ling
    Yang, Xin-Yun
    Zeng, Jun
    Deng, Qiu-Hua
    He, Jian-Xing
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 861 - 867
  • [2] The prognostic value of gene expressions of ERCC1 and RRM1 in non-small cell lung cancer.
    Hasturk, Serap
    Olgunus, Ozlem
    Tuli, Abdullah
    Dundar, Ebru
    Unlu, Emine Ozgur
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Ercc1 And Rrm1 Expression Patterns Are Promising Prognostic Indicators Of Patients With Non-Small Cell Lung Cancer
    Jiang, J.
    Han, J.
    Zhang, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [4] Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
    Pesta, M.
    Kulda, V.
    Fiala, O.
    Safranek, J.
    Topolcan, O.
    Krakorova, G.
    Pesek, M.
    Cerny, R.
    [J]. FEBS JOURNAL, 2012, 279 : 105 - 105
  • [5] Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer
    A. Lafuente-Sanchis
    Á. Zúñiga
    J. M. Galbis
    A. Cremades
    M. Estors
    N. J. Martínez-Hernández
    J. Carretero
    [J]. Clinical and Translational Oncology, 2016, 18 : 798 - 804
  • [6] Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer
    Lafuente-Sanchis, A.
    Zuniga, A.
    Galbis, J. M.
    Cremades, A.
    Estors, M.
    Martinez-Hernandez, N. J.
    Carretero, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (08): : 798 - 804
  • [7] Prognostic Significance of ERCC1, RRM1 and BRCA1 in Surgically-treated Patients with Non-small Cell Lung Cancer
    Pesta, Martin
    Kulda, Vlastimil
    Fiala, Ondrej
    Safranek, Jarmil
    Topolcan, Ondrej
    Krakorova, Gabriela
    Cerny, Radim
    Pesek, Milos
    [J]. ANTICANCER RESEARCH, 2012, 32 (11) : 5003 - 5010
  • [8] Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
    Martin Pesta
    Ondrej Topolcan
    Vlastimil Kulda
    Ondrej Fiala
    Gabriela Krakorova
    Radim Cerny
    Milos Pesek
    [J]. EPMA Journal, 2014, 5 (Suppl 1):
  • [9] Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
    Martin, Pesta
    Vlastimil, Kulda
    Ondrej, Fiala
    Jarmil, Safranek
    Ondrej, Topolcan
    Gabriela, Krakorova
    Radim, Cerny
    Milos, Pesek
    [J]. TUMOR BIOLOGY, 2012, 33 : 93 - 93
  • [10] Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy
    Zhao, Hui
    Zhang, Huawei
    Du, Yonghai
    Gu, Xiaomeng
    [J]. TUMOR BIOLOGY, 2014, 35 (12) : 12679 - 12688
12345